Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

95
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
95
Hazard Rate01:11

Hazard Rate

88
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
88
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

146
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
Hazard Ratio01:12

Hazard Ratio

85
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
85
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

299
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
299

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same author

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same author

Global Sensitivity Analysis for Studies Extending Inferences From a Randomized Trial to a Target Population.

Statistics in medicine·2026
Same author

Statins and risk of cardiovascular disease: Emulating a primary prevention trial in breast cancer survivors.

Journal of the National Cancer Institute·2026
Same author

Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial.

Lancet (London, England)·2026
Same author

Extending inferences from a randomized trial to trial-eligible and treatment-candidate target populations: examples of generalizability and transportability.

Epidemiology (Cambridge, Mass.)·2026

相关实验视频

Updated: Jun 4, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

为什么要使用需要相应危险的方法呢?

Mats J Stensrud1, Miguel A Hernàn2,3

  • 1Institute of Mathematics, Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland, and CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA.

American journal of epidemiology
|January 5, 2025
PubMed
概括
此摘要是机器生成的。

对于医学研究,尤其是随机试验,生存分析中的比例危险假设往往是不必要的和不可信的. 避免这种假设的替代生存分析方法通常是可取的.

关键词:
因果推断的原因推断是因果推断.危险比率 危险比率相称的危险相称的危险生存分析的分析.

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

相关实验视频

Last Updated: Jun 4, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

科学领域:

  • 生物统计学 生物统计学
  • 医学统计 医学统计
  • 临床试验 临床试验

背景情况:

  • 生存分析是一种统计方法,用于分析一个有趣事件发生之前的时间.
  • 比例危险 (PH) 假设是某些生存分析模型的常见要求,例如Cox比例危险模型.
  • 这种假设假定任何两个个体之间的危险比率随着时间的推移而保持不变.

研究的目的:

  • 批判性地评估医学研究中比例危险假设的必要性和合理性.
  • 倡导使用不依赖于比例危险假设的替代生存分析技术.
  • 引导研究人员选择适当的统计方法进行时间到事件数据分析.

主要方法:

  • 在生存分析的背景下,对比例危险假设的审查和批评.
  • 讨论医学研究中违反比例危险假设的后果.
  • 探索替代的生存分析方法,放松或不需要比例危险假设.

主要成果:

  • 在现实世界的医学数据中,比例危险假设经常被违反,特别是在随机对照试验中.
  • 对比例危险的测试可能是复杂的,可能并不总是产生明确的结果.
  • 替代性生存分析方法提供了更大的灵活性和稳定性,当比例危险假设是可疑的.

结论:

  • 在许多医学研究中,比例危险假设往往是不可信的和不必要的.
  • 研究人员应考虑并使用不依赖于比例危险假设的生存分析方法.
  • 采用没有比例危险假设的方法可以在生存数据分析中获得更可靠和更可解释的结果.